Home » Topics » BioWorld Science

BioWorld Science
RSS

Tobishi reports outstanding selectivity of it's CCK-A antagonist

May 10, 1996

James Black Foundation describes CCK-B/gastrin receptor antagonist

May 10, 1996

TBC-11241 protects against dye-induced hemodynamic changes in rats

May 10, 1996

L-Arginine potential for treating interstitial cystitis

May 10, 1996

Terflavoxate development halted

May 10, 1996

Terazosin and finasteride go head-to-head in VA study

May 10, 1996

Novel non-pharmaceutical approach to BPH presented

May 10, 1996

Terazosin and finasteride reduce PSA serum levels: Implications for diagnostic testing

May 10, 1996

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...